Clinical Trials
3 trialsActive not recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Inotuzumab Ozogamicin × Clear all
NCT05456698 2026-04-16
Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Active not recruiting
NCT03441061 2026-02-17
Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07238907 2025-11-25
A Multi-center Retrospective Study of INO Treating B-ALL
Ruijin Hospital
Active not recruiting